Literature DB >> 10344009

Gene therapy for a lethal genetic blistering disease: a status report.

E A Bauer1, G S Herron, M P Marinkovich, P A Khavari, A T Lane.   

Abstract

Mesh:

Year:  1999        PMID: 10344009      PMCID: PMC2194312     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN: 0065-7778


× No keyword cloud information.
  8 in total

1.  Epidermolysis bullosa simplex: evidence in two families for keratin gene abnormalities.

Authors:  J M Bonifas; A L Rothman; E H Epstein
Journal:  Science       Date:  1991-11-22       Impact factor: 47.728

Review 2.  Hemidesmosomal variants of epidermolysis bullosa. Mutations in the alpha6beta4 integrin and the 180-kD bullous pemphigoid antigen/type XVII collagen genes.

Authors:  L Pulkkinen; J Uitto
Journal:  Exp Dermatol       Date:  1998 Apr-Jun       Impact factor: 3.960

3.  Gamma 2 chain of laminin-5 is recognized by monoclonal antibody GB3.

Authors:  C Matsui; C F Nelson; G T Hernandez; G S Herron; E A Bauer; W K Hoeffler
Journal:  J Invest Dermatol       Date:  1995-11       Impact factor: 8.551

4.  Gene therapy: progress, problems, prospects.

Authors:  H Blau; P Khavari
Journal:  Nat Med       Date:  1997-06       Impact factor: 53.440

5.  Point mutations in human keratin 14 genes of epidermolysis bullosa simplex patients: genetic and functional analyses.

Authors:  P A Coulombe; M E Hutton; A Letai; A Hebert; A S Paller; E Fuchs
Journal:  Cell       Date:  1991-09-20       Impact factor: 41.582

6.  The assembly of laminin-5 subunits.

Authors:  C Matsui; C K Wang; C F Nelson; E A Bauer; W K Hoeffler
Journal:  J Biol Chem       Date:  1995-10-06       Impact factor: 5.157

7.  Premature termination codons in the type VII collagen gene (COL7A1) underlie severe, mutilating recessive dystrophic epidermolysis bullosa.

Authors:  A M Christiano; G Anhalt; S Gibbons; E A Bauer; J Uitto
Journal:  Genomics       Date:  1994-05-01       Impact factor: 5.736

8.  Recessive dystrophic epidermolysis bullosa phenotype is preserved in xenografts using SCID mice: development of an experimental in vivo model.

Authors:  Y H Kim; D T Woodley; K C Wynn; W Giomi; E A Bauer
Journal:  J Invest Dermatol       Date:  1992-02       Impact factor: 8.551

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.